Mexico Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012

Global Markets Direct, December 2008, Pages: 98

Mexico Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to Mexico neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the neurology devices in Mexico

Scope

- The report provides neurology devices information broken down into detailed categories and segments in Mexico.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the neurology devices market in Mexico.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About? 11
3 Definitions of Markets Covered in the Report 12
3.1 Neurology Devices 12
3.2 CSF (Cerebro Spinal Fluid) Management 12
3.2.1 Hydrocephalus shunt 12
3.2.2 Intra Cranial Pressure (ICP) Monitors 12
3.3 Interventional Neurology 12
3.3.1 Aneurysm Clips 12
3.3.2 Embolic System 12
3.3.3 Navigational System 13
3.4 Neurostimulation Device 13
3.4.1 Spinal Cord Stimulator (SCS) 13
3.4.2 Deep Brain Stimulator (DBS) 13
3.4.3 Vagus Nerve stimulation (VNS) 13
3.5 Neurosurgical Products (Neuroendoscopes) 14
3.5.1 Neurosurgical Products (Neuroendoscopes) 14
3.6 Radio surgery 14
3.6.1 Cyber Knife Radiosurgery 14
3.6.2 Gamma Knife Radiosurgery 14
4 Healthcare Sector Review 15
5 Regulation System 16
5.1 Device Classification 16
5.2 Registration Process 16
5.3 Labeling Requirements 18
5.4 Import Documentation 19
6 Pricing and Reimbursement 20
7 Distribution Structure 21
8 Neurology Devices In Mexico 22
8.1 Neurology Devices Cross Country Comparison (2000-2012) 22
8.2 Neurology Devices, Mexico, Overall Revenues ($ mn), 2000-2012 23
8.3 Neurology Devices, Mexico, Category Volume (Units), 2000-2012 27
8.4 Neurology Devices, Mexico, Company Share (2006-2007) 29
9 CSF Management In Mexico 30
9.1 CSF Management Overall Revenue (2000-2012) 30
9.2 CSF Management Overall Volume (2000-2012) 32
9.3 CSF Management Average Price (2000-2012) 34
9.4 CSF Management Distribution Share (2006-2007) 35
9.5 CSF Management, Mexico, Company Share (2006-2007) 36
10 Interventional Neurology In Mexico 37
10.1 Interventional Neurology Overall Revenue (2000-2012) 37
10.1.1 Embolic Systems Overall Revenues (2000-2012) 39
10.1.2 Navigational Systems Overall Revenues (2000-2012) 41
10.2 Interventional Neurology Overall Volume (2000-2012) 43
10.2.1 Embolic Systems Overall Volume (2000-2012) 45
10.2.2 Navigational Systems Overall Volume (2000-2012) 47
10.3 Interventional Neurology Average Price (2000-2012) 49
10.4 Interventional Neurology Distribution Share (2006-2007) 50
10.5 Interventional Neurology, Mexico, Company Share (2006-2007) 51
11 Neurostimulation Devices In Mexico 52
11.1 Neurostimulation Devices Overall Revenue (2000-2012) 52
11.2 Neurostimulation Devices Overall Volume (2000-2012) 54
11.3 Neurostimulation Devices Average Price (2000-2012) 56
11.4 Neurostimulation Devices Distribution Share (2006-2007) 57
11.5 Neurostimulation Devices, Mexico, Company Share (2006-2007) 58
12 Neurosurgical Products (Neuroendoscopes) In Mexico 59
12.1 Neurosurgical Products (Neuroendoscopes) Overall Revenue (2000-2012) 59
12.2 Neurosurgical Products (Neuroendoscopes) Overall Volume (2000-2012) 61
12.3 Neurosurgical Products (Neuroendoscopes) Average Price (2000-2012) 63
12.4 Neurosurgical Products (Neuroendoscopes) Distribution Share (2006-2007) 64
12.5 Neurosurgical Products (Neuroendoscopes), Mexico, Company Share (2006-2007) 65
13 Medtronic, Inc. Company Profile 66
13.1 Company Overview 66
13.2 Value Chain Analysis 66
13.2.1 Manufacturing 67
13.2.2 Product Development 67
13.2.3 Sales and Marketing 67
13.3 Medtronic, Inc. Pipeline Products 68
13.3.1 Medtronic, Inc. Pipeline Products By Equipment Type 68
13.3.2 Medtronic, Inc. Pipeline Products by Development Stage 70
13.3.3 Medtronic, Inc. Pipeline Products by Therapy Area 72
13.3.4 Medtronic, Inc. Pipeline Products by Clinical Trials 74
13.3.5 Medtronic, Inc. Pipeline Products by News Summary 75
14 B. Braun Melsungen AG Company Profile 76
14.1 Company Overview 76
14.2 Value Chain Analysis 76
14.2.1 Manufacturing 77
14.2.2 Product Development 77
14.2.3 Sales and Marketing 78
14.2.4 B. Braun Melsungen AG Pipeline Products by Equipment Type 79
14.2.5 B. Braun Melsungen AG Pipeline Products by Development Stage 79
14.2.6 B. Braun Melsungen AG Pipeline Products by Therapy Area 79
14.2.7 B. Braun Melsungen AG Pipeline Products by Clinical Trials 80
14.2.8 B. Braun Melsungen AG Pipeline Products by News Summary 80
15 Codman & Shurtleff, Inc. Company Profile 81
15.1 Company Overview 81
16 Boston Scientific Corporation Company Profile 82
16.1 Company Overview 82
16.2 Value Chain Analysis 82
16.2.1 Manufacturing 83
16.2.2 Product Development 83
16.2.3 Sales and Marketing 84
16.3 Boston Scientific Corporation Pipeline Products 85
16.3.1 Boston Scientific Corporation Pipeline Products by Equipment Type 85
16.3.2 Boston Scientific Corporation Pipeline Products by Development Stage 86
16.3.3 Boston Scientific Corporation Pipeline Products by Therapy Area 87
16.3.4 Boston Scientific Corporation Pipeline Products by Clinical Trials 88
16.3.5 Boston Scientific Corporation Pipeline Products by News Summary 89
17 Cyberonics, Inc. Company Profile 91
17.1 Company Overview 91
17.1.1 Cyberonics, Inc. Pipeline Products by Equipment Type 92
17.1.2 Cyberonics, Inc. Pipeline Products by Development Stage 92
17.1.3 Cyberonics, Inc. Pipeline Products by Therapy Area 92
18 Appendix 93
18.1 Global Markets Direct Research Methodology 93
18.2 Coverage 94
18.3 Secondary Research 94
18.4 Primary Research 95
18.5 Models 95
18.6 Forecasts 96
18.7 Expert Panels 96
18.8 Currency Conversion 97
18.9 Contact Us 98
18.10 Disclaimer 98

Executive Summary

1.2 List of Figures
Figure 1: Neurology Devices Cross Country Comparison (2000-2012) 22
Figure 2: Neurology Devices, Mexico, Overall Revenues ($ mn), 2000-2012 23
Figure 3: Neurology Devices, Mexico, Portfolio Analysis, 2000-2012 24
Figure 4: Neurology Devices, Mexico, Overall Revenues ($ mn), Historic, 2000-2007 25
Figure 5: Neurology Devices, Mexico, Overall Revenues ($ mn), Forecast, 2007-2012 26
Figure 6: Neurology Devices, Mexico, Company Share (%), 2007 29
Figure 7: CSF Management, Mexico, Revenue ($ mn), Historic, 2000-2007 30
Figure 8: CSF Management, Mexico, Revenue ($ mn), Forecast, 2007-2012 31
Figure 9: CSF Management, Mexico, Overall Volume (Units), Historic, 2000-2007 32
Figure 10: CSF Management, Mexico, Overall Volume (Units), Forecast, 2007-2012 33
Figure 11: CSF Management, Mexico, Company Share (%), 2007 36
Figure 12: Interventional Neurology, Mexico, Revenue ($ mn) by Segment, Historic, 2000-2007 37
Figure 13: Interventional Neurology, Mexico, Revenue ($ mn) by Segment, Forecast, 2007-2012 38
Figure 14: Embolic Systems, Mexico, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 39
Figure 15: Embolic Systems, Mexico, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 40
Figure 16: Navigational Systems, Mexico, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 41
Figure 17: Navigational Systems, Mexico, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 42
Figure 18: Interventional Neurology, Mexico, Overall Volume (Units), Historic, 2000-2007 43
Figure 19: Interventional Neurology, Mexico, Overall Volume (Units), Forecast, 2007-2012 44
Figure 20: Embolic Systems, Mexico, Volume (Units) by Sub-Segment, Historic, 2000-2007 45
Figure 21: Embolic Systems, Mexico, Volume (Units) by Sub-Segment, Forecast, 2007-2012 46
Figure 22: Navigational Systems, Mexico, Volume (Units) by Sub-Segment, Historic, 2000-2007 47
Figure 23: Navigational Systems, Mexico, Volume (Units) by Sub-Segment, Forecast, 2007-2012 48
Figure 24: Interventional Neurology, Mexico, Company Share (%), 2007 51
Figure 25: Neurostimulation Devices, Mexico, Revenue ($ mn), Historic, 2000-2007 52
Figure 26: Neurostimulation Devices, Mexico, Revenue ($ mn), Forecast, 2007-2012 53
Figure 27: Neurostimulation Devices, Mexico, Overall Volume (Units), Historic, 2000-2007 54
Figure 28: Neurostimulation Devices, Mexico, Overall Volume (Units), Forecast, 2007-2012 55
Figure 29: Neurostimulation Devices, Mexico, Company Share (%), 2007 58
Figure 30: Neurosurgical Products (Neuroendoscopes), Mexico, Revenue ($ mn), Historic, 2000-2007 59
Figure 31: Neurosurgical Products (Neuroendoscopes), Mexico, Revenue ($ mn), Forecast, 2007-2012 60
Figure 32: Neurosurgical Products (Neuroendoscopes), Mexico, Overall Volume (Units), Historic, 2000-2007 61
Figure 33: Neurosurgical Products (Neuroendoscopes), Mexico, Overall Volume (Units), Forecast, 2007-2012 62
Figure 34: Neurosurgical Products (Neuroendoscopes), Mexico, Company Share (%), 2007 65
Figure 35: Medtronic, Inc. Value Chain Analysis 66
Figure 36: B. Braun Melsungen AG Value Chain Analysis 76
Figure 37: Boston Scientific Corporation Value Chain Analysis 82
Figure 38: Global Markets Direct Methodology 93

Medtronic, Inc.
B. Braun Melsungen AG
Codman & Shurtleff, Inc.
Boston Scientific Corporation
Cyberonics, Inc.

Customers who bought this item also bought

• Neurology Devices Market Outlook in Mexico to 2017 - Neurostimulation Devices, Interventional Neurology and Other
• South and Central America Neurology Devices Market Outlook to 2017
• Drug Delivery Devices Market Outlook in Mexico to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
• Mexico Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices
• Medical Nutrition - A Global Market Overview
• Cord Blood Stem Cells – A Global Market Overview
• Mexico Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others
• Mexico In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
• ENT Devices Market Outlook in Mexico to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices
• Nephrology and Urology Devices Market Outlook in Mexico to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others